SCHEMBL7449743

SCHEMBL7449743

C#CCCC(=O)C(C)[C](C)C

nearest known ligand 0.34

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.34
CYP1A2 P05177 1/20 0.34
CYP2D6 P10635 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
HSD17B10 Q99714 1/20 0.34
ALDH1A1 P00352 2/20 0.31
KDM4E B2RXH2 1/20 0.31
HPGD P15428 1/20 0.31
MEN1 O00255 1/20 0.30
USP2 O75604 1/20 0.30
TP53 P04637 1/20 0.30
CYP3A4 P08684 1/20 0.30
MAPK1 P28482 1/20 0.30
KMT2A Q03164 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9911540 0.79
SCHEMBL14021268 0.74 CYP1A2 (0.34) MAPTCYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL1415277 0.71
SCHEMBL22883555 0.70
SCHEMBL17107802 0.69 CYP1A2 (0.31) MAPTCYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL15489317 0.67 CYP1A2 (0.45) MAPTCYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL10233612 0.65 CNR1 (0.33) MAPTCYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL7449748 0.65 CA1 (0.43) MAPTCYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL21205940 0.65 CYP1A2 (0.34) MAPTCYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL11033182 0.65 CYP1A2 (0.34) MAPTCYP1A2CYP2D6CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2001079177-A1 CYCLIC DIAZA COMPOUNDS FOR TREATING NEURODEGENERATIVE DISORDERS GPI NIL HOLDINGS, INC. (US) 2001-10-25 WO disclosed